What have we learnt from previous phase II trials to help in the management of childhood brain tumours? (Q34399296)

1 August 2017

1 reference

title

What have we learnt from previous phase II trials to help in the management of childhood brain tumours? (English)

1 reference

1 August 2017

main subject

phase II clinical trial

0 references

author name string

Chastagner P

1

1 reference

1 August 2017

Bouffet E

2

1 reference

1 August 2017

Grill J

3

1 reference

1 August 2017

Kalifa C

4

1 reference

1 August 2017

publication date

1 November 2001

1 reference

European Journal of Cancer

1 August 2017

published in

1 reference

1 August 2017

volume

37

1 reference

1 August 2017

issue

16

1 reference

1 August 2017

page(s)

1981-1993

1 reference

1 August 2017

cites work

Brain tumors in children

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00251-9

7 January 2021

Carboplatin and VP 16 in medulloblastoma: a phase II Study of the French Society of Pediatric Oncology (SFOP).

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00251-9

7 January 2021

Intratumoral histologic heterogeneity of gliomas. A quantitative study

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00251-9

7 January 2021

Radiation therapy treatment planning in supratentorial glioblastoma multiforme: an analysis based on post mortem topographic anatomy with CT correlations.

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00251-9

7 January 2021

Multidrug resistance gene expression in pediatric primitive neuroectodermal tumors of the central nervous system

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00251-9

7 January 2021

Prospective randomised trial of chemotherapy given before radiotherapy in childhood medulloblastoma. International Society of Paediatric Oncology (SIOP) and the (German) Society of Paediatric Oncology (GPO): SIOP II.

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00251-9

7 January 2021

Improving survival in recurrent medulloblastoma: earlier detection, better treatment or still an impasse?

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00251-9

7 January 2021

Recommendations of the Brain Tumor Subcommittee for the reporting of trials. SIOP Brain Tumor Subcommittee. International Society of Pediatric Oncology

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00251-9

7 January 2021

Comparison of lumbar and shunt cerebrospinal fluid specimens for cytologic detection of leptomeningeal disease in pediatric patients with brain tumors

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00251-9

7 January 2021

Corticosteroid-induced magnetic resonance imaging changes in patients with recurrent malignant glioma.

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00251-9

7 January 2021

The determinatio of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agent

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00251-9

7 January 2021

Carboplatin and recurrent childhood brain tumors

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00251-9

7 January 2021

Carboplatin in childhood brain tumors. A Children's Cancer Study Group Phase II trial

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00251-9

7 January 2021

Treatment of children with progressive or recurrent brain tumors with carboplatin or iproplatin: a Pediatric Oncology Group randomized phase II study

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00251-9

7 January 2021

Carboplatin for the treatment of children with newly diagnosed optic chiasm gliomas: a phase II study

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00251-9

7 January 2021

Carboplatin in childhood medulloblastoma/PNET: feasibility of an in vivo sensitivity test in an "up-front" study.

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00251-9

7 January 2021

A phase II trial of preirradiation carboplatin in newly diagnosed germinoma of the central nervous system

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00251-9

7 January 2021

Cisplatin in recurrent pediatric brain tumors. A POG Phase II study. A Pediatric Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00251-9

7 January 2021

Cisplatin in the treatment of recurrent childhood primary brain tumors

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00251-9

7 January 2021

A phase II study of cisplatin therapy in recurrent childhood brain tumors. A report from the Childrens Cancer Study Group.

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00251-9

7 January 2021

Phase II study of ifosfamide in childhood brain tumors: a report by the French Society of Pediatric Oncology (SFOP).

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00251-9

7 January 2021

A phase II study of every other day high-dose ifosfamide in pediatric brain tumors: a Pediatric Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00251-9

7 January 2021

Cyclophosphamide in combination with sargramostim for treatment of recurrent medulloblastoma

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00251-9

7 January 2021

Dose escalation trial of cyclophosphamide with Sargramostim in the treatment of central nervous system (CNS) neoplasms

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00251-9

7 January 2021

Cyclophosphamide for the treatment of progressive low-grade astrocytoma: a Pediatric Oncology Group phase II Study

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00251-9

7 January 2021

Phase II treatment of medulloblastoma and pineoblastoma with melphalan: clinical therapy based on experimental models of human medulloblastoma

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00251-9

7 January 2021

PCNU in the treatment of recurrent medulloblastoma and ependymoma--a POG Study

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00251-9

7 January 2021

PCNU and recurrent childhood brain tumors

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00251-9

7 January 2021

A phase II evaluation of thiotepa in pediatric central nervous system malignancies

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00251-9

7 January 2021

A Phase II clinical trial of idarubicin administered to children with relapsed brain tumors

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00251-9

7 January 2021

Phase II evaluation of topotecan for pediatric central nervous system tumors

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00251-9

7 January 2021

Topotecan for the treatment of recurrent or progressive central nervous system tumors - a pediatric oncology group phase II study

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00251-9

7 January 2021

Recurrent chiasmatic-hypothalamic glioma treated with oral etoposide

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00251-9

7 January 2021

Oral methotrexate for recurrent brain tumors in children: a Pediatric Oncology Group study.

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00251-9

7 January 2021

Pre-radiation chemotherapy for infants and poor prognosis children with medulloblastoma.

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00251-9

7 January 2021

Preirradiation cisplatin and etoposide in the treatment of high-risk medulloblastoma and other malignant embryonal tumors of the central nervous system: a phase II study

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00251-9

7 January 2021

Lack of efficacy of postoperative chemotherapy and delayed radiation in very young children with pineoblastoma. Pediatric Oncology Group

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00251-9

7 January 2021

Efficacy of vincristine and cyclophosphamide in the therapy of recurrent medulloblastoma.

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00251-9

7 January 2021

Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas.

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00251-9

7 January 2021

Preirradiation chemotherapy with carboplatin and etoposide in newly diagnosed embryonal pediatric CNS tumors

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00251-9

7 January 2021

Chemotherapy with vincristine (VCR) and etoposide (VP-16) in children with low-grade astrocytoma

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00251-9

7 January 2021

Tamoxifen and carboplatin for children with low-grade gliomas: a pilot study at St. Jude Children's Research Hospital.

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00251-9

7 January 2021

Efficacy of adjuvant chemotherapy for patients with poor-risk medulloblastoma: a preliminary report

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00251-9

7 January 2021

Salvage chemotherapy for recurrent primary brain tumors in children

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00251-9

7 January 2021

Preradiation chemotherapy in advanced medulloblastoma. A Pediatric Oncology Group pilot study

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00251-9

7 January 2021

Eight drugs in one day chemotherapy for brain tumors: experience in 107 children and rationale for preradiation chemotherapy

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00251-9

7 January 2021

Feasibility of sequential high-dose chemotherapy and peripheral blood stem cell support for pediatric central nervous system malignancies

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00251-9

7 January 2021

Pilot study of high-dose thiotepa and etoposide with autologous bone marrow rescue in children and young adults with recurrent CNS tumors. The Children's Cancer Group

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00251-9

7 January 2021

Etoposide and thiotepa followed by ABMT (autologous bone marrow transplantation) in children and young adults with high-grade gliomas.

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00251-9

7 January 2021

High-dose chemotherapy and autologous bone marrow rescue followed by interstitial and external-beam radiotherapy in newly diagnosed pediatric malignant gliomas

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00251-9

7 January 2021

Survival following intensive chemotherapy with bone marrow reconstitution for children with recurrent intracranial ependymoma--a report of the Children's Cancer Group

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00251-9

7 January 2021

High-dose chemotherapy in childhood brain tumours

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00251-9

7 January 2021

A high-dose busulfan-thiotepa combination followed by autologous bone marrow transplantation in childhood recurrent ependymoma. A phase-II study

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00251-9

7 January 2021

Radiotherapy followed by high dose busulfan and thiotepa: a prospective assessment of high dose chemotherapy in children with diffuse pontine gliomas.

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00251-9

7 January 2021

High dose chemotherapy with autologous bone marrow rescue for children with diffuse pontine brain stem tumors. Children's Cancer Group

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00251-9

7 January 2021

Paclitaxel as a radiosensitizer combined with fractionated stereotactic radiotherapy in the treatment of recurrent medulloblastoma.

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00251-9

7 January 2021

Pre-irradiation chemotherapy in children with high-grade astrocytoma: tumor response to two cycles of the '8-drugs-in-1-day' regimen. A Childrens Cancer Group study, CCG-945.

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00251-9

7 January 2021

Treatment of chiasmatic/hypothalamic gliomas of childhood with chemotherapy: an update

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00251-9

7 January 2021

Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy.

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00251-9

7 January 2021

Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group Study.

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00251-9

7 January 2021

Adjuvant chemotherapy of childhood posterior fossa ependymoma: cranio-spinal irradiation with or without adjuvant CCNU, vincristine, and prednisone: a Childrens Cancer Group study.

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00251-9

7 January 2021

Busulphan is active against neuroblastoma and medulloblastoma xenografts in athymic mice at clinically achievable plasma drug concentrations

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00251-9

7 January 2021

Response of brain tumors to chemotherapy, evaluated in a clinically relevant xenograft model

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00251-9

7 January 2021

Preclinical development of camptothecin derivatives and clinical trials in pediatric oncology.

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00251-9

7 January 2021

Enhancement of nitrosourea activity in medulloblastoma and glioblastoma multiforme.

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00251-9

7 January 2021

10.1016/S0959-8049(01)00251-9

Identifiers

DOI

1 reference

1 August 2017

1 reference